Advertisement

Topics

Companies Related to "Noblegen Announces Opening Second Round Financing Peterborough Based" [Most Relevant Company Matches] RSS

11:31 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "Noblegen Announces Opening Second Round Financing Peterborough Based" found in our extensive corporate database of over 50,000 company records.

Showing "Noblegen Announces Opening Second Round Financing Peterborough Based" Companies 1–25 of 5,600+

Relevant

Symphogen A/S

Symphogen A/S, the biotech company pioneering recombinant human polyclonal antibodies for the treatment and prevention of human disease, today announced the initial closing of a USD 25 million Series D financing at a premium to the last financing round.


De Novo Pharmaceuticals

The commercial focus of De Novo is the exploitation of human genomics in drug discovery through in silico drug design. The company attracted £2 million financing in a first VC-backed investment round in April 2000, followed by a second round of funding of £16.75 million in July 2001. Investors in the first round included Avlar Bioventures, Prelude Technology and Cambridge Research and Innovati...

Skada Capital

Skada Capital (www.skadacapital.com) is a Maryland-based provider of financing solutions to healthcare, government contracting and technology companies in the Mid-Atlantic region. With over 200 sources of capital in its network, Skada Capital tailors solutions for companies seeking cash flow financing or growth capital for expansion. Skada Capital speciali...


Combinature Biopharm AG

Combinature Biopharm AG was founded in 2000 by scientists and managers, including professors and other members of staff, from the Universities of Freiburg and Tübingen, the Research Institute for Molecular Pharmacology, Berlin, and the German Resource Center for Genome Research, Berlin. The company is located on Berlin´s leading biomedical research campus and rents approximately 1,300 square met...

KfW

The SME sector is the backbone of the German economy. 3.3 million SMEs continually face new challenges – many of which involve finding the right type of financing. The KfW Mittelstandsbank offers SMEs, business start-ups and the self-employed support with this. In the form of loans, mezzanine financing, equity capital and consulting services. All investment projects that we assist are tied to a ...

Applied Genetic Technologies, Corporation,

Applied Genetic Technologies Corporation (AGTC) was founded in January, 1999 by five scientific leaders in the use of viral vectors for Gene Therapy. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus (AAV) to gene therapy. Since that time the Company has grown to 15 employees (including 6 Ph.D.s), signed licens...

St. David?s Round Rock Medical Center

St. David's Round Rock Medical Center, located adjacent to downtown Round Rock on FM 620, off of IH-35, provides comprehensive health services to residents of Williamson and surrounding counties. Services include The Heart and Vascular Center with express testing, inpatient capacity of 184 beds with private rooms, The Women's Center and a thriving Emergency Room. The medical staff at St. David's R...

ProMAC

ProMAC was founded in 2007 and is headquartered in Hauppauge, NY. ProMAC offers fast and flexible alternatives to bank loans and factoring services by financing a business’ future receivables. ProMAC is the first financing company that can fund against all types of electronic payments proceeds such as ACH, Credit Card Receipts, and Health Insurance...

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a privately held biopharmaceutical company focused on applying a novel, small molecule immunotherapy platform to treat severe fungal infections in immune-compromised patients. Cidara recently announced that it has completed a $32 million Series A financing that will enable it to advance candidates from the company’s Cloudb...

St. David's Round Rock Medical Center

St. David's Round Rock Medical Center, located in Round Rock at 2400 Round Rock Avenue, is owned by St. David's HealthCare, one of the largest health systems in Texas. With more than 170 beds, this acute care hospital provides comprehensive health services to residents of Williamson County and the surrounding areas. Services include The Heart and Vascular Center with express testing, maternity and...

Pieris AG

Pieris was established in January 2001 with the vision of commercially exploiting technologies developed originally by Prof. Dr. Arne Skerra, Head of the Department of Biological Chemistry at the Technical University of Munich (TUM), Germany. While the scientific excellence of Prof. Dr. Skerra and his fellow Pieris co-founders has long been recognized by the academic community, the product commerc...

Rodin Therapeutics

Rodin Therapeutics is discovering and developing first in class therapeutics for cognitive disorders, applying unique insights into the role of epigenetics and best in class structural biology capabilities. Rodin closed a $12.9m Series A financing round in May 2014, and was co-founded in 2013 by Atlas Venture and Proteros Biostructures.

BookJane Inc.

BookJane is a visionary startup that through the use of its technologies, is addressing the inefficiencies in finding certified caregiver professionals when needed. Initially developed for internal use, BookJane’s technologies is now being deployed as a SaaS platform for business customers’ internal use in the United States and Canada. With the i...

Albireo AB

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfill unmet medical needs in the gastrointestinal (GI) area. The Albireo team has a broad experience in drug development, primarily in the GI area and has an extensive network in the international scientific and clinical communities. Albireo was created as a spin out of...

Trinity Biosystems, Inc

Trinity Biosystems, Inc., was founded in 2002 to commercialize a unique platform technology originally developed at the NIH/NCI. The company received its initial seed financing in 2002 in a Series A round led by Sanderling Ventures.The Founder and Chief Scientific Officer, Randy Mrsny, Ph.D., has more than 20 years experience in research and development and has worked at ALZA and Genentech. He is ...

Osprey Pharmaceuticals U.S.A., Inc.

Osprey Pharmaceuticals U.S.A. is focused on the development of protein therapeutics for the treatment of inflammatory and autoimmune conditions based on the company's proprietary therapeutic platform of Leukocyte Population Modulators (LPMs). Osprey Pharmaceuticals U.S.A. is advancing a pipeline of proprietary LPMs, novel fusion protein therapeutics designed to selectively and systematically neutr...

SightLine Partners

SightLine Partners manages a series of private equity funds that provide creative financing solutions to later stage medical device and diagnostic companies and financial alternatives to the existing investors in these companies. SightLine’s investment focus since early 2009 has been to provide financial alternatives to existing investors in late stag...

Familybuilder.com

Familybuilder is a NYC-based software company that builds genealogy and family-oriented applications. Familybuilder is the only genealogy service to run a family tree application on all the major social networks (Facebook, Bebo, MySpace, Hi5, and Orkut) and is the only genealogy service to bridge together family trees across these networks and the Internet at-large. Familybuilder is quickly be...

Echo, Inc.

Victory Junction is a year-round camping environment for children, ages six to 16, with chronic medical conditions or serious illnesses. Founded by Kyle and Pattie Petty in honor of their son Adam, the camp is located in Randleman, N.C. with a second location opening soon in Kansas City, Kan. Victory Junction offers programs for 24 disease groups and maintains strong relationships with 30 partner ...

High-Tech Gründerfonds Management GmbH

We Shape Up Young Technology Companies for the Market. There's no doubt that German research occupies a premium standing in international comparison. However, far too few of its results flow onto the German market. Technological company foundations help to balance this deficit by transferring technologies from science to commercial applications. Particularly at the beginning, high-tech companies r...

GE Capital, Healthcare Financial Services

With over $17 billion invested in more than 30 sub-sectors including senior housing, hospitals, pharmaceuticals, and medical devices, GE Capital, Healthcare Financial Services is a premier provider of capital and services to the healthcare industry. Our team of professionals provides deep industry expertise to create business and financial solutions tailor...

VENTECH

Ventech is a French Venture Capital firm founded in 1998 and regulated by the French Financial Authority -AMF- (GP 98-39). Ventech currently manages €173 million through two funds.Ventech invests in the first institutional round of financing in start-up companies active in Information Technology and Biotechnology, mainly in France.Our mission is to invest in ambitious projects with a potential t...

Principia Biopharma Inc.

Principia Biopharma is a privately-held biopharmaceutical company focused on the discovery and development of best-in-class small molecule drugs for autoimmune diseases and cancer. The company uses its proprietary technology, licensed from the University of California San Francisco, to enable a new approach to making small molecules that are potent, safe a...

Genetics Squared, Inc

Located in Ann Arbor, Michigan, Genetics Squared was founded in 2001 to commercialize the use of patented analysis technology. Over the past three years the company has proven the value of its technology and methods through academic and industry collaborations applied to a variety of applications in drug discovery and development.The company has achieved several important milestones including the ...

Western Technology Investment

Western Technology Investment is focused on expanding this productive partnership between venture capital investors and venture lenders.A pioneer in this separate industry segment, WTI specializes in asset based financing for venture capital funded technology companies, both in their start-up and later stages. Our experience working with early stage companies enables us to more effectively finance...


More From BioPortfolio on "Noblegen Announces Opening Second Round Financing Peterborough Based"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks